Biological Aging Clock Using Deep Neural Networks

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current strategies for senescence reversal lack methods for rapid screening, validation, and clinical deployment, and there is a need for timely prediction of drug effects on human longevity and health span, with existing biomarkers being inadequate for accurately measuring biological aging across multiple physiological systems.

Innovation Solution

The development of a method using deep neural networks and machine learning to analyze transcriptomic and proteomic data for predicting biological age, allowing for personalized senescence therapies and the identification of targets for anti-aging treatments by generating biological aging clocks specific to tissues or organs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If deep neural networks and machine learning are used to analyze transcriptomic and proteomic data for predicting biological age, then measurement precision of biological aging is improved, but device complexity and computational requirements increase

Engineering Contradiction:
Improvebiological age prediction accuracyVSAvoidcomputational system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the complex biological aging prediction task into distinct computational modules: transcriptomic data processing, proteomic data processing, and integrated machine learning analysis. This segmentation allows each module to be optimized independently while maintaining overall system accuracy.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces computational intermediaries including trained neural network models and pre-processed feature sets that mediate between raw transcriptomic/proteomic data and final biological age predictions. These intermediaries simplify the complexity by encapsulating complex relationships in reusable computational components.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If comprehensive transcriptomic and proteomic analysis is performed to accurately measure biological aging across multiple physiological systems, then measurement precision is improved, but loss of time for data processing and analysis increases

Engineering Contradiction:
Improvebiological aging assessment accuracyVSAvoiddata processing time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent applies preliminary action by pre-training machine learning models on extensive transcriptomic and proteomic datasets before actual biological age prediction. This pre-processing creates ready-to-use computational models that can rapidly predict biological age without requiring real-time comprehensive analysis of all data during actual use.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent transforms comprehensive transcriptomic and proteomic data into simplified parameter representations that capture essential aging information. By changing the parameters from raw data to processed features, the system maintains measurement precision while reducing processing time for subsequent analysis.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If tissue-specific gene expression and protein production profiles are analyzed to develop personalized senescence reversal treatments, then adaptability of treatment is improved, but device complexity and analysis requirements increase

Engineering Contradiction:
Improvepersonalized treatment capabilityVSAvoidanalysis system complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent applies local quality by analyzing tissue-specific gene expression and protein production profiles rather than treating all tissues uniformly. This allows the system to adapt treatments to the specific characteristics of each tissue, improving personalization while managing complexity through focused local analysis rather than comprehensive global analysis.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS10665326B2Deep proteome markers of human biological aging and methods of determining a biological aging clock
Publication Date: 2020.05.26 INSILICO MEDICINE IP LTD
  • US10665326B2 patent drawing
  • US10665326B2 patent drawing
  • US10665326B2 patent drawing

AI summary

A method of creating a biological aging clock for a subject can include: (a) receiving a proteome signature derived from a tissue or organ of the subject; (b) creating input vectors based on the proteome signature; (c) inputting the input vectors into a machine learning platform; (d) generating a predicted biological aging clock of the tissue or organ based on the input vectors by the machine learning platform, wherein the biological aging clock is specific to the tissue or organ; and (e) preparing a report that includes the biological aging clock that identifies a predicted biological age of the tissue or organ.